185 related articles for article (PubMed ID: 33882197)
1. Orthotopic Human Metastatic Uveal Melanoma Xenograft Mouse Models: Applications for Understanding the Pathophysiology and Therapeutic Management of Metastatic Uveal Melanoma.
Terai M; Kageyama K; Sugase T; Lam BQ; Alexeev V; Sato T
Curr Protoc; 2021 Apr; 1(4):e110. PubMed ID: 33882197
[TBL] [Abstract][Full Text] [Related]
2. Development and optimization of orthotopic liver metastasis xenograft mouse models in uveal melanoma.
Sugase T; Lam BQ; Danielson M; Terai M; Aplin AE; Gutkind JS; Sato T
J Transl Med; 2020 May; 18(1):208. PubMed ID: 32434572
[TBL] [Abstract][Full Text] [Related]
3. Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis.
Kageyama K; Ohara M; Saito K; Ozaki S; Terai M; Mastrangelo MJ; Fortina P; Aplin AE; Sato T
J Transl Med; 2017 Jun; 15(1):145. PubMed ID: 28645290
[TBL] [Abstract][Full Text] [Related]
4. Orthotopic murine xenograft model of uveal melanoma with spontaneous liver metastasis.
Ramos R; Cabré E; Vinyals A; Lorenzo D; Ferreres JR; Varela M; Gomá M; Paules MJ; Gutierrez C; Piulats JM; Fabra À; Caminal JM
Melanoma Res; 2023 Feb; 33(1):1-11. PubMed ID: 36302215
[TBL] [Abstract][Full Text] [Related]
5. Generation of a Liver Orthotopic Human Uveal Melanoma Xenograft Platform in Immunodeficient Mice.
Kageyama K; Ozaki S; Sato T
J Vis Exp; 2019 Nov; (153):. PubMed ID: 31762467
[TBL] [Abstract][Full Text] [Related]
6. Establishment and Characterization of Orthotopic Mouse Models for Human Uveal Melanoma Hepatic Colonization.
Ozaki S; Vuyyuru R; Kageyama K; Terai M; Ohara M; Cheng H; Manser T; Mastrangelo MJ; Aplin AE; Sato T
Am J Pathol; 2016 Jan; 186(1):43-56. PubMed ID: 26613897
[TBL] [Abstract][Full Text] [Related]
7. Effect of anti-ganglioside antibodies on the metastatic spread of intraocular melanomas in a nude mouse model of human uveal melanoma.
Niederkorn JY; Mellon J; Pidherney M; Mayhew E; Anand R
Curr Eye Res; 1993 Apr; 12(4):347-58. PubMed ID: 8319494
[TBL] [Abstract][Full Text] [Related]
8. Whole-body bioluminescent imaging of human uveal melanoma in a new mouse model of local tumor growth and metastasis.
Notting IC; Buijs JT; Que I; Mintardjo RE; van der Horst G; Karperien M; Missotten GS; Jager MJ; Schalij-Delfos NE; Keunen JE; van der Pluijm G
Invest Ophthalmol Vis Sci; 2005 May; 46(5):1581-7. PubMed ID: 15851554
[TBL] [Abstract][Full Text] [Related]
9. Animal Models of Uveal Melanoma: Methods, Applicability, and Limitations.
Stei MM; Loeffler KU; Holz FG; Herwig MC
Biomed Res Int; 2016; 2016():4521807. PubMed ID: 27366747
[TBL] [Abstract][Full Text] [Related]
10. Modeling the behavior of uveal melanoma in the liver.
Folberg R; Leach L; Valyi-Nagy K; Lin AY; Apushkin MA; Ai Z; Barak V; Majumdar D; Pe'er J; Maniotis AJ
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):2967-74. PubMed ID: 17591861
[TBL] [Abstract][Full Text] [Related]
11. Natural killer cells and pigment epithelial-derived factor control the infiltrative and nodular growth of hepatic metastases in an Orthotopic murine model of ocular melanoma.
Jones NM; Yang H; Zhang Q; Morales-Tirado VM; Grossniklaus HE
BMC Cancer; 2019 May; 19(1):484. PubMed ID: 31117965
[TBL] [Abstract][Full Text] [Related]
12. Using the direct-injection model of early uveal melanoma hepatic metastasis to identify TPS as a potentially useful serum biomarker.
Barak V; Frenkel S; Valyi-Nagy K; Leach L; Apushkin MA; Lin AY; Kalickman I; Baumann NA; Pe'er J; Maniotis AJ; Folberg R
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4399-402. PubMed ID: 17898257
[TBL] [Abstract][Full Text] [Related]
13. Hepatic Ultrasonography for Surveillance in Patients With Uveal Melanoma.
Choudhary MM; Gupta A; Bena J; Emch T; Singh AD
JAMA Ophthalmol; 2016 Feb; 134(2):174-80. PubMed ID: 26633182
[TBL] [Abstract][Full Text] [Related]
14. Modeling of human uveal melanoma in zebrafish xenograft embryos.
van der Ent W; Burrello C; Teunisse AF; Ksander BR; van der Velden PA; Jager MJ; Jochemsen AG; Snaar-Jagalska BE
Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6612-22. PubMed ID: 25249605
[TBL] [Abstract][Full Text] [Related]
15. Locoregional management of hepatic metastasis from primary uveal melanoma.
Sato T
Semin Oncol; 2010 Apr; 37(2):127-38. PubMed ID: 20494705
[TBL] [Abstract][Full Text] [Related]
16. Crizotinib, a c-Met inhibitor, prevents metastasis in a metastatic uveal melanoma model.
Surriga O; Rajasekhar VK; Ambrosini G; Dogan Y; Huang R; Schwartz GK
Mol Cancer Ther; 2013 Dec; 12(12):2817-26. PubMed ID: 24140933
[TBL] [Abstract][Full Text] [Related]
17. Update on posterior uveal melanoma: treatment of the eye and emerging strategies in the prognosis and treatment of metastatic disease.
Shildkrot Y; Wilson MW
Curr Opin Ophthalmol; 2009 Nov; 20(6):504-10. PubMed ID: 19644367
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic options in metastatic uveal melanoma.
Mariani P; Servois V; Piperno-Neumann S
Dev Ophthalmol; 2012; 49():166-181. PubMed ID: 22042020
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA in exosomes isolated directly from the liver circulation in patients with metastatic uveal melanoma.
Eldh M; Olofsson Bagge R; Lässer C; Svanvik J; Sjöstrand M; Mattsson J; Lindnér P; Choi DS; Gho YS; Lötvall J
BMC Cancer; 2014 Dec; 14():962. PubMed ID: 25510783
[TBL] [Abstract][Full Text] [Related]
20. Uveal melanoma: physiopathology and new in situ-specific therapies.
Souto EB; Zielinska A; Luis M; Carbone C; Martins-Gomes C; Souto SB; Silva AM
Cancer Chemother Pharmacol; 2019 Jul; 84(1):15-32. PubMed ID: 31079217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
